CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

Effect of improved door-to-balloon time on clinical outcomes in patients with ST segment elevation myocardial infarction SCAI Clinical Expert Consensus Statement on Cardiogenic Shock Comparison of Outcomes of Patients With ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention Analyzed by Age Groups (<75, 75 to 85, and >85 Years); (Results from the Bremen STEMI Registry) Recurrent Cardiovascular Events in Survivors of Myocardial Infarction with St-Segment Elevation (From the AMI-QUEBEC Study) TACIT (High Sensitivity Troponin T Rules Out Acute Cardiac Insufficiency Trial): An Observational Study to Identify Acute Heart Failure Patients at Low Risk for Rehospitalization or Mortality Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Wearable Cardioverter-Defibrillator after Myocardial Infarction Coronary Angiography in Patients With Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation: A Systematic Review and Meta-Analysis

Clinical Trial2018 Feb;15(2):117-122.

JOURNAL:J Geriatr Cardiol. Article Link

Comparison of the safety and efficacy of two types of drug-eluting balloons (RESTORE DEB and SeQuent® Please) in the treatment of coronary in-stent restenosis: study protocol for a randomized controlled trial (RESTORE ISR China)

Gao L, Qin Q, Chen SL et al. Keywords: drug-coated balloon; drug-eluting stent(s); in-segment late loss; in-stent restenosis

FULL TEXT PDF